This clone belongs to a unique set of HIV-2 biological clones from West African immigrants in The Netherlands. Clones were obtained from patients with non-progressive, aviremic or progressive, viremic HIV-2 infection.
Unit: Vial with 1 ml infectious culture supernatant.
This clone belongs to a unique set of HIV-2 biological clones from West African immigrants in The Netherlands. Clones were obtained from patients with non-progressive, aviremic or progressive, viremic HIV-2 infection.
Unit: Vial with 1 ml infectious culture supernatant
This clone belongs to a unique set of HIV-2 biological clones from West African immigrants in The Netherlands. Clones were obtained from patients with non-progressive, aviremic or progressive, viremic HIV-2 infection.
Unit: Vial with 1 ml infectious culture supernatant
This clone belongs to a unique set of HIV-2 biological clones from West African immigrants in The Netherlands. Clones were obtained from patients with non-progressive, aviremic or progressive, viremic HIV-2 infection.
Unit: Vial with 1 ml infectious culture supernatant.
This clone belongs to a unique set of HIV-2 biological clones from West African immigrants in The Netherlands. Clones were obtained from patients with non-progressive, aviremic or progressive, viremic HIV-2 infection.
Unit: Vial with 1 ml infectious culture supernatant.
This clone belongs to a unique set of HIV-2 biological clones from West African immigrants in The Netherlands. Clones were obtained from patients with non-progressive, aviremic or progressive, viremic HIV-2 infection.
Unit: Vial with 1 ml infectious culture supernatant.
This clone belongs to a unique set of HIV-2 biological clones from West African immigrants in The Netherlands. Clones were obtained from patients with non-progressive, aviremic or progressive, viremic HIV-2 infection.
Unit: Vial with 1 ml infectious culture supernatant.
This clone belongs to a unique set of HIV-2 biological clones from West African immigrants in The Netherlands. Clones were obtained from patients with non-progressive, aviremic or progressive, viremic HIV-2 infection.
Unit: Vial with 1 ml infectious culture supernatant
This clone belongs to a unique set of HIV-2 biological clones from West African immigrants in The Netherlands. Clones were obtained from patients with non-progressive, aviremic or progressive, viremic HIV-2 infection.
Unit: Vial with 1 ml infectious culture supernatant.
This clone belongs to a unique set of HIV-2 biological clones from West African immigrants in The Netherlands. Clones were obtained from patients with non-progressive, aviremic or progressive, viremic HIV-2 infection.
Unit: Vial with 1 ml infectious culture supernatant.
This clone belongs to a unique set of HIV-2 biological clones from West African immigrants in The Netherlands. Clones were obtained from patients with non-progressive, aviremic or progressive, viremic HIV-2 infection.
Unit: Vial with 1 ml infectious culture supernatant.
This clone belongs to a unique set of HIV-2 biological clones from West African immigrants in The Netherlands. Clones were obtained from patients with non-progressive, aviremic or progressive, viremic HIV-2 infection.
Unit: Vial with 1 ml infectious culture supernatant.
This clone belongs to a unique set of HIV-2 biological clones from West African immigrants in The Netherlands. Clones were obtained from patients with non-progressive, aviremic or progressive, viremic HIV-2 infection.
Unit: Vial with 1 ml infectious culture supernatant.
Through direct cloning and expression of the variable heavy chains (VHHs) of HCAbs from the bone marrow of MERS-CoV infected dromedaries, MERS-CoV specific VHHs or nanobodies were produced. VHH-83 binds with exceptionally high affinity to the receptor binding domain of the viral spike protein. In vitro, this VHH efficiently blocks virus entry at picomolar concentrations
